echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > China Resources Double-Crane: Parecoxib sodium for injection obtained drug registration certificate

    China Resources Double-Crane: Parecoxib sodium for injection obtained drug registration certificate

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 4, China Resources Shuanghe stated that it had received the "Drug Registration Certificate" (Certificate Number: 2021S00561) for Parecoxib Sodium for Injection issued by the National Medical Products Administration, and the drug was approved for production
    .

    This medicine is used for short-term treatment of pain after surgery
    .

    The original parecoxib sodium for injection was jointly developed by Pfizer and Pharmacia.
    It was first launched in Europe in March 2002 under the trade name "Dynastat".
    It was approved to be marketed in China in May 2008 under the trade name "Tenai".

    .


    So far, the drug has been marketed in more than a dozen countries including the European Union and China


    According to the global drug sales database of 71 countries, in 2020, the global sales of parecoxib sodium for injection will be 269 million US dollars
    .


    Among them, "Dynastat" global sales of 121 million US dollars


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.